Volume 26 continues the trend of shorter, more frequent volumes. With Volume 25, the series gained a new co-editor, Urs Meyer. While retaining the commitment to publish chapters on therapeutic or chemical classes and on general topics or concepts, the series' coverage has expanded to include methodological chapters, and new areas of recognized or potential significance to drug research, especially in molecular pharmacology.
Author(s): Bernard Testa, Urs A. Meyer (Eds.)
Edition: 1st
Publisher: Academic Press
Year: 1995
Language: English
Pages: 1-279
Content:
Contributors
Page vii
Preface
Pages ix-xi
Bernard Testa, Urs A. Meyer
Complexity and emergence in drug research Original Research Article
Pages 1-43
Lemont B. Kier, Bernard Testa
Drug design: the present and the future Original Research Article
Pages 45-142
M.S. Tute
Transgenic animals as pharmacological tools Original Research Article
Pages 143-177
Kurt Bürki, Birgit Ledermann
Xenobiotic-metabolizing human cells as tools for pharmacological and toxicological research Original Research Article
Pages 179-235
Charles L. Crespi
Correlates of variable patient compliance in drug trials: Relevance in the new health care environment Original Research Article
Pages 237-257
John Urquhart
Subject index
Pages 259-272
Cumulative index of authors
Pages 273-275
Cumulative index of titles
Pages 277-279
